// App-Quantinova.ai

S4341 2015 AHA : Prevention of HeartMate II Pump Thrombosis - Recommendations and Preliminary Observations From the PREVENT Study

Researchers

Presenter

  • Mary Keebler

Principal Investigators

  • John M. Ransom

  • Nir Uriel

  • John B -Connell

  • David Farrar

  • Kartik Sundareswaran

  • Simon Maltais

  • Ahmet Kilic

  • Gregory Egnacyzk

  • Robert Gallegos

  • Paul Mather

  • John Stulak

  • Igor Gregoric

  • Jason Katz

  • Charles T Klodell Jr

Medical Centers

  • Vanderbilt University, Nashville, TN

  • Univ of Chicago, Chicago, IL

  • Shands Transplant Ctr, Univ of Florida, Gainsville, FL

  • Mayo Clinic, Rochester, MN

  • UNC Heart & Vascular Ctr, Chapel Hill, NC

  • Baptist Health Little Rock, Little Rock, AR

  • The Ohio State Univerisity, Columbus, OH

  • Christ Hosp, Cincinnati, OH

  • Jefferson, Philadelphia, PA

  • Memorial Hermann Hospital, Houston, TX

  • Thoratec Corporation, Plesenton, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • single arm

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved